Archive
Back to homepage
Community Living & Respite Services celebrates its latest disability housing project with solar systems donated by GoodWe and Collaborators
MELBOURNE, Australia, May 28, 2024 /PRNewswire/ — GoodWe has contributed to Community Living and Respite Services’ (CLRS) latest housing project for people with disabilities by donating solar inverters, helping long-term energy cost reduction for the new homes. the latest Opening
Read More
On-us Selected for the Prestigious Visa Accelerator Program, Revolutionizing Loyalty of the Future
HONG KONG, SINGAPORE and TAIPEI, May 28, 2024 /PRNewswire/ — On-us Company Limited (“On-us“ or the “Company”), a leading fintech innovator specializing in comprehensive incentive ecosystems, is thrilled to announce its selection into the highly competitive Visa Accelerator Program. This
Read More
“Bleach: Brave Souls” to be Released on the Nintendo Switch & Xbox with Thousand-Year Blood War Zenith Summons: Gravitation Featuring New Versions of Masaki and Isshin to Begin May 31
TOKYO, May 28, 2024 /PRNewswire/ — KLab Inc. announced that its hit 3D action game Bleach: Brave Souls will be released on the Nintendo Switch and Xbox consoles this summer. See the original press release (https://www.klab.com/en/press/) for more information. KLab
Read More
Philippines DITO Hits Major Milestone: Phase One of 5G SA Core Network Self-Owned Data Center Relocation Successfully Completed
MANILA, Philippines, May 28, 2024 /PRNewswire/ — Based on recent statistics, approximately 50 operators worldwide have accomplished 5G SA deployment. Among other operators presently constructing their 5G SA Core Network, DITO stands out as an exemplary representative of SA Core
Read More
An Interview with Siju Daniel, Chief Commercial Officer of ATFX
HONG KONG, May 28, 2024 /PRNewswire/ — With seasoned leaders joining the ranks, ATFX is set to navigate new horizons in the financial services realm. Today Siju Daniel, Chief Commercial Officer of ATFX, will share his vision for driving global business
Read More
Meiyume Debuts at Cosmoprof CBE Asean Bangkok: Pioneering the Future of Beauty Innovation with Sustainability and Smart Technology
BANGKOK and HONG KONG, May 28, 2024 /PRNewswire/ — Meiyume, a B2B leading force in beauty innovation, proudly announces its inaugural debut at Cosmoprof CBE Asean Bangkok, offering beauty solutions that harmoniously blend sustainability, smart technology, and insight-driven products. Under
Read More
Grubtech Raises $15 Million
Led by Jahez Group, funds will accelerate geographic expansion into Saudi Arabia, Europe and the UK DUBAI, UAE, May 28, 2024 /PRNewswire/ — Grubtech, a leading SaaS integration and unified commerce platform that empowers F&B and Quick Commerce enterprises, announced
Read More
YCYW Listed in Forbes China’s Top 20 Innovative Brands — the Only One Selected from the Education Sector
GUANGZHOU, China, May 16, 2024 /PRNewswire/ — The “2024 Forbes China Brand Development Forum,” jointly hosted by Forbes China and Bingo Consult, concluded in Guangzhou on 26 April. The Yew Chung Yew Wah Education Network (YCYW) was listed as one of the
Read More
Labuan IBFC Inc. and RAM jointly host event on Labuan captive solutions for self-insurance
This collaboration arises from RAM’s LECA® rating service for credit and performance evaluation of Labuan IBFC licensees KUALA LUMPUR, Malaysia, May 16, 2024 /PRNewswire/ — RAM Rating Services Berhad (RAM Ratings), Malaysia’s premier rating agency, and Labuan IBFC Incorporated Sdn Bhd
Read More![HSA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults [1]](https://theleaders-online.com/wp-content/uploads/2024/05/hsa-approves-gsks-arexvy-the-worlds-first-respiratory-syncytial-virus-rsv-vaccine-for-older-adults-1-150x150.jpg)
HSA approves GSK’s Arexvy, the world’s first respiratory syncytial virus (RSV) vaccine for older adults [1]
Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.[2] Arexvy is
Read More